Role of Arrhythmic Phenotype in Prognostic Stratification and Management of Dilated Cardiomyopathy
European Journal of Heart Failure · 2024
DOI: 10.1002/ejhf.3168 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2024. Verfasst von Martina Setti und 17 weiteren Autor:innen. Beteiligte Einrichtung: Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), Univers…. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Phenotype, Death, Sudden, Cardiac. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Aims
Dilated cardiomyopathy (DCM) with arrhythmic phenotype combines phenotypical aspects of DCM and predisposition to ventricular arrhythmias, typical of arrhythmogenic cardiomyopathy. The definition of DCM with arrhythmic phenotype is not universally accepted, leading to uncertainty in the identification of high-risk patients. This study aimed to assess the prognostic impact of arrhythmic phenotype in risk stratification and the correlation of arrhythmic markers with high-risk arrhythmogenic gene variants in DCM patients. Methods and results In this multicentre study, DCM patients with available genetic testing were analysed. The following arrhythmic markers, present at baseline or within 1 year of enrolment, were tested: unexplained syncope, rapid non-sustained ventricular tachycardia (NSVT), ≥1000 premature ventricular contractions/24 h or ≥50 ventricular couplets/24 h. LMNA, FLNC, RBM20, and desmosomal pathogenic or likely pathogenic gene variants were considered high-risk arrhythmogenic genes. The study endpoint was a composite of sudden cardiac death and major ventricular arrhythmias (SCD/MVA). We studied 742 DCM patients (45 ± 14 years, 34% female, 410 [55%] with left ventricular ejection fraction [LVEF] <35%). During a median follow-up of 6 years (interquartile range 1.6–12.1), unexplained syncope and NSVT were the only arrhythmic markers associated with SCD/MVA, and the combination of the two markers carried a significant additive risk of SCD/MVA, incremental to LVEF and New York Heart Association class. The probability of identifying an arrhythmogenic genotype rose from 8% to 30% if both early syncope and NSVT were present.
Conclusion
In DCM patients, the combination of early detected NSVT and unexplained syncope increases the risk of life-threatening arrhythmic outcomes and can aid the identification of carriers of malignant arrhythmogenic genotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
- Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.
- Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
- Cardiovascular Institute and Adult Medical Genetics Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- Biostatistics Unit, University of Trieste, Trieste, Italy.
- MOX-Modeling and Scientific Computing Laboratory, Department of Mathematics, Politecnico di Milano, Milan, Italy.
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Setti, M., Merlo, M., Gigli, M., Munaretto, L., Paldino, A., Stolfo, D., Pio Loco, C., Medo, K., Gregorio, C., De Luca, A., Graw, S., Castrichini, M., Cannatà, A., Ribichini, F. L., Dal Ferro, M., Taylor, M., Sinagra, G., & Mestroni, L. (2024). Role of Arrhythmic Phenotype in Prognostic Stratification and Management of Dilated Cardiomyopathy. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3168
Vancouver
Setti M, Merlo M, Gigli M, Munaretto L, Paldino A, Stolfo D, et al. Role of Arrhythmic Phenotype in Prognostic Stratification and Management of Dilated Cardiomyopathy. European Journal of Heart Failure. 2024. doi:10.1002/ejhf.3168
BibTeX
@article{Setti2024,
author = {Setti, Martina and Merlo, Marco and Gigli, Marta and Munaretto, Laura and Paldino, Alessia and Stolfo, Davide and Pio Loco, Carola and Medo, Kristen and Gregorio, Caterina and De Luca, Antonio and Graw, Sharon and Castrichini, Matteo and Cannatà, Antonio and Ribichini, Flavio Luciano and Dal Ferro, Matteo and Taylor, Matthew and Sinagra, Gianfranco and Mestroni, Luisa},
title = {Role of Arrhythmic Phenotype in Prognostic Stratification and Management of Dilated Cardiomyopathy},
journal = {European Journal of Heart Failure},
year = {2024},
doi = {10.1002/ejhf.3168}
}
EUVIMED